XTRA:SHLMedical Equipment
Is Strong Imaging-Led Growth and Higher Cash Flow Altering The Investment Case For Siemens Healthineers (XTRA:SHL)?
Earlier this week, Siemens Healthineers reported nearly 6% year-over-year revenue growth for Q1 FY2025, with adjusted EBIT rising 11% and free cash flow expanding by a very large margin, driven primarily by strong performance in the Imaging and Varian segments.
Management reaffirmed its full-year 2025 guidance of 5–6% revenue growth and stable adjusted EPS, showing continued confidence despite ongoing challenges in China and tariff risks.
We'll explore how Siemens Healthineers' reaffirmed...